Related references
Note: Only part of the references are listed.Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143
Qing An et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance
Zhennan Yuan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
PAN-cancer analysis of S-phase enriched IncRNAs identifies oncogenic drivers and biomarkers
Mohamad Moustafa Ali et al.
NATURE COMMUNICATIONS (2018)
The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer
Luqing Zhao et al.
CELLULAR SIGNALLING (2018)
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer
Hu YiRen et al.
MOLECULAR CANCER (2017)
Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes
Dongbo Zhou et al.
MOLECULAR MEDICINE REPORTS (2017)
DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression
Michela Borghesan et al.
CANCER RESEARCH (2016)
Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference
Yi Zhang et al.
ONCOLOGY REPORTS (2016)
STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7
Jiayu Chen et al.
CANCER CELL INTERNATIONAL (2015)
Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma
Huaqiang Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Circulating Hepatocellular Carcinoma Cells are Characterized by CXCR4 and MMP26
Chang Yu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
Jessica Lo et al.
HEPATOLOGY (2015)
A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
Yu Yang et al.
LIVER INTERNATIONAL (2015)
Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2
Ming-De Huang et al.
MOLECULAR CANCER (2015)
LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition
Yuehua Han et al.
BMC CANCER (2014)
Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma
Yang Deng et al.
CANCER LETTERS (2014)
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma
Igor P. Pogribny et al.
CANCER LETTERS (2014)
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
Mario Scartozzi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Identification of Transmembrane Protein 98 as a Novel Chemoresistance-Conferring Gene in Hepatocellular Carcinoma
Kevin Tak-Pan Ng et al.
MOLECULAR CANCER THERAPEUTICS (2014)
MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1
C. Gao et al.
NEOPLASMA (2014)
The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression
Suna Zhou et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
Yong Yang et al.
PLOS ONE (2013)
Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells
W. P. Tsang et al.
ONCOGENE (2007)
Share Paper
